Life Sciences Tools and Services
Company Overview of QIAGEN A.S.
QIAGEN A.S. develops magnetic bead technology based reagents and solutions for nucleic acid diagnostic markets. It offers nucleic acid purification solutions, including BioRobot M48 and BioRobot M96 workstations for the purification of DNA and RNA from various blood and tissue samples, sources, including dried blood, leukocytes, serum, buccal cells, cultured cells, biopsies, paraffinembedded tissue sections, animal tissue, and yeast cells. The company was formerly knwon as GenoVision A.S. and changed its name to QIAGEN A.S. in June, 2002. The company was founded in 1998 and is based in Oslo, Norway. As of June 14, 2002 QIAGEN A.S. operates as a subsidiary of QIAGEN N.V.
Founded in 1998
47 23 00 53 53
47 23 00 53 50
Key Executives for QIAGEN A.S.
QIAGEN A.S. does not have any Key Executives recorded.
Similar Private Companies By Industry
|AME Bioscience A/S||Europe|
|APIM Therapeutics AS||Europe|
|Biosense Laboratories AS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact QIAGEN A.S., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.